# Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

Study · id `cardio:ct-nct01115855` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01115855](<https://clinicaltrials.gov/study/NCT01115855>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01115855

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

## Technical summary

Registry record NCT01115855. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2016-10-27.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 221 participants (enrolled count; ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Results first posted: 2016-10-27 (ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT01115855, source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01115855-2020-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
- Acronym: J-EMPHASIS-HF
- Condition: Heart Failure
- Intervention (Drug): Eplerenone
- Intervention (Drug): Placebo
- Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (`cardio:org-pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Eplerenone in Japanese Patients With Chronic Heart Failure (J-EMPHASIS-HF) (`cardio:pubmed-28824029`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 44e714b50e407718c63d03c5e6345cc50b42b521e858b8afad4cfbd28a1df6e8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
